Takeda在印度首次推出创新能力中心, Takeda launches its first Innovation Capability Center in India, aiming to boost healthcare with AI and data analytics.

日本一家制药公司Takeda在印度孟加拉鲁启动了第一个创新能力中心(ICC),目标是到2025年雇用750多名专业人员。 Takeda, a Japanese pharmaceutical company, has launched its first Innovation Capability Center (ICC) in Bengaluru, India, aiming to hire over 750 professionals by 2025. 该中心将侧重于AI、数据分析以及数字保健,以加强病人护理和简化医疗保健业务。 The center will focus on AI, data analytics, and digital health to enhance patient care and streamline healthcare operations. Takeda还计划扩大肿瘤学和罕见疾病等领域, 重点是印度的“Make in India”方案下的本地制造业。 Takeda also plans to expand in areas like oncology and rare diseases, with a focus on local manufacturing under India's 'Make in India' program. 该公司的登革热疫苗,Qdenga, 预定在经管制批准后2026年在印度发射。 The company's Dengue vaccine, Qdenga, is set for launch in India by 2026 after regulatory approvals.